JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $509,699 | +66.7% | 275,513 | 0.0% | 0.33% | +222.3% |
Q4 2022 | $305,819 | -52.6% | 275,513 | 0.0% | 0.10% | -56.4% |
Q3 2022 | $645,000 | -22.8% | 275,513 | 0.0% | 0.24% | -11.6% |
Q2 2022 | $835,000 | -55.4% | 275,513 | 0.0% | 0.27% | -30.3% |
Q1 2022 | $1,871,000 | -18.7% | 275,513 | 0.0% | 0.38% | +17.8% |
Q4 2021 | $2,301,000 | +12.4% | 275,513 | 0.0% | 0.32% | +41.3% |
Q3 2021 | $2,047,000 | +9.3% | 275,513 | 0.0% | 0.23% | +8.5% |
Q2 2021 | $1,873,000 | -33.8% | 275,513 | 0.0% | 0.21% | -20.9% |
Q1 2021 | $2,830,000 | +20.7% | 275,513 | -17.7% | 0.27% | -23.9% |
Q4 2020 | $2,345,000 | -14.2% | 334,965 | 0.0% | 0.35% | -52.4% |
Q3 2020 | $2,733,000 | -25.3% | 334,965 | -36.8% | 0.74% | -26.1% |
Q2 2020 | $3,657,000 | +45.3% | 529,965 | 0.0% | 1.00% | -4.0% |
Q1 2020 | $2,517,000 | -45.6% | 529,965 | 0.0% | 1.04% | -29.3% |
Q4 2019 | $4,627,000 | +162.2% | 529,965 | 0.0% | 1.47% | +170.3% |
Q3 2019 | $1,765,000 | -32.7% | 529,965 | 0.0% | 0.54% | -18.5% |
Q2 2019 | $2,623,000 | -60.1% | 529,965 | -50.0% | 0.67% | -51.8% |
Q1 2019 | $6,572,000 | +268.0% | 1,059,930 | +100.0% | 1.39% | +4.9% |
Q4 2018 | $1,786,000 | -48.2% | 529,965 | 0.0% | 1.32% | -18.8% |
Q3 2018 | $3,445,000 | -15.1% | 529,965 | 0.0% | 1.63% | -45.6% |
Q2 2018 | $4,060,000 | -65.7% | 529,965 | 0.0% | 3.00% | -74.3% |
Q1 2018 | $11,845,000 | +60.3% | 529,965 | -8.6% | 11.64% | +117.8% |
Q4 2017 | $7,391,000 | -18.2% | 579,650 | 0.0% | 5.34% | +4.6% |
Q3 2017 | $9,031,000 | +11.1% | 579,650 | 0.0% | 5.11% | +0.7% |
Q2 2017 | $8,132,000 | -36.2% | 579,650 | 0.0% | 5.08% | -38.8% |
Q1 2017 | $12,747,000 | – | 579,650 | – | 8.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |